OPERATING SYSTEM OF LIFE
LIVE

Serial Number

79292986

Owner

Bit Bio Limited

Attorney

Katrina G. Hull

Filing Date

May 11, 2020

Add to watchlist:

No watchlists yet
View on USPTO

OPERATING SYSTEM OF LIFE Trademark

Serial Number: 79292986 • Registration: 6982346

OPERATING SYSTEM OF LIFE is a trademark filed by Bit Bio Limited on May 11, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

Bit Bio Limited (21 trademarks)

Pioneer House,
Cambridge, Cambridgeshire CB24 9NL , GB

Entity Type: 99

Trademark Details

Filing Date

May 11, 2020

Registration Date

February 21, 2023

Published for Opposition

May 18, 2021

Goods & Services

Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; Genetically or otherwise modified cells for medical or clinical use; Cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; Cells for the purpose of tissue regeneration for medical, therapeutic or clinical use; Living cells for medical use; Cells for medical use; Diagnostic preparations for medical and veterinary purposes; Cell preparations for medical use in drug screening; Cell preparations for genetic testing and screening for medical purposes or clinical use; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical or diagnostic use; Tissue culture media, growth factors in the nature of cell growth, cell growth media, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, all for medical or clinical use; Cell separation reagents for medical and clinical use; Dietary supplements; Protein supplements; nutrition supplements

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; Smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; Electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation equipment, namely, apparatus for the separation of cell populations for medical or clinical use; all of the foregoing excluding vaccines and RNA-based therapeutics

Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Skeletal myocytes for research purposes; Cortical neurons for research purposes; Biological human tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media for scientific or research use; Chemical reagents for use in biotechnology, other than for medical or veterinary use; Nutritive agents for processing living cells; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technology; cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical research; all of the foregoing excluding vaccines and RNA-based therapeutics

Meat; Meat substitutes; Tissue engineered meat; Synthetic meat; Cultured meat; Laboratory-grown meat; Fish, not live

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, Stem cells for scientific purposes, Stem cells other than for medical or veterinary purposes, Skeletal myocytes for research purposes, Cortical neurons for research purposes, Biological tissue for research and scientific purposes, Biological tissue cultures other than for medical or veterinary purposes, Cultures of cell media other than for medical or veterinary use, Chemical reagents for use in biotechnology, other than for medical or veterinary use, Nutritive agents for processing living cells other than for medical use, Semi-processed natural proteins for manufacturing food, Proteins for use in the manufacture of food products, Proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, Genetically or otherwise modified cells, Cells which are propagated, cultivated and expanded in bioreactors, Cells for the purpose of tissue regeneration, Living cells for medical use, Cells for medical use, Biological preparations for medical use, Diagnostic preparations for medical and/or veterinary purposes, Cell preparations for drug screening, Cell preparations for genetic testing, screening, Stem cells for medical purposes, Stem cells for veterinary purposes, Cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, Tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, Cell separation reagents, magnetic cell separation equipment, Dietary supplements, Protein supplements, nutrition supplements, Meat, Meat substitutes, Tissue engineered meat, Synthetic meat, Cultured meat, Laboratory-grown meat and Fish, not live; all of the foregoing excluding vaccines and RNA-based therapeutics

Biotechnology research; Scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; Stem cell research; Synthetic biology services, namely, biological research; Stem cell biology services, namely, biological research; Scientific services for scientific, research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testing, screening; Research and development in relation to drug screening; Cell separation technology services for scientific, research, clinical, therapeutic and manufacturing purposes; Cell separation research services for scientific, research, clinical, therapeutic and manufacturing purposes; Consultancy relating to biotechnology; Scientific and research consultancy relating to drug screening; Scientific and research consultancy relating to genetic screening; Scientific and research consultancy relating to cell therapy; Laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and biomanufacturing; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions; all of the foregoing excluding vaccines and RNA-based therapeutics

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 8, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 4, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 12, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 22, 2023 FICS
FINAL DISPOSITION PROCESSED
May 22, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 21, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 21, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 21, 2023 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Jan 12, 2023 TMBN
OPPOSITION TERMINATED NO. 999999
Jan 12, 2023 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 12, 2023 OP.D
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 11, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 24, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 24, 2022 OPNR
REFUSAL PROCESSED BY IB
Oct 25, 2021 RFNP
OPPOSITION INSTITUTED NO. 999999
Sep 16, 2021 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Sep 13, 2021 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Sep 13, 2021 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 9, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 18, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 18, 2021 PUBO
NOTIFICATION PROCESSED BY IB
May 17, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 28, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 28, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 28, 2021 NONP
WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
Apr 12, 2021 ISMR
ATTORNEY REVIEW COMPLETED
Apr 9, 2021 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Apr 9, 2021 CREV
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 23, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 22, 2021 GPNX
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 20, 2021 CRCV
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 3, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 3, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 15, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2021 TROA
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Jan 5, 2021 LOPR
LETTER OF PROTEST EVIDENCE FORWARDED
Dec 7, 2020 LOPT
REFUSAL PROCESSED BY IB
Oct 19, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 30, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 30, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 9, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 8, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 8, 2020 MAFR
ASSIGNED TO EXAMINER
Sep 4, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 3, 2020 REPR